| 12134636 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Rui Zhang, Martin A. Case, Mark Wall, Yue-Mei Zhang +9 more |
2024-11-05 |
$502,780,000 |
| 12018057 |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
Chengzao Sun, Brian Troy Frederick, Sandeep Somani, Ashok Bhandari, Stephanie A. BARROS +4 more |
2024-06-25 |
$184,084,000 |
| 11845808 |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
Chengzao Sun, Brian Troy Frederick, Sandeep Somani, Gregory Thomas Bourne, Ashok Bhandari |
2023-12-19 |
$136,773,000 |
| 11767354 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2023-09-26 |
$256,124,000 |
| 11732019 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Mark Wall, Yue-Mei Zhang |
2023-08-22 |
$233,822,000 |
| 11591379 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2023-02-28 |
$178,787,000 |
| 11401315 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2022-08-02 |
$336,434,000 |
| 10968264 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Yue-Mei Zhang, Mark Wall |
2021-04-06 |
$118,870,000 |
| 10968265 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2021-04-06 |
$118,870,000 |
| 10961293 |
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Mark Wall, Yue-Mei Zhang |
2021-03-30 |
$81,035,000 |
| 10858413 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Rui Zhang, Martin A. Case, Mark Wall, Yue-Mei Zhang +9 more |
2020-12-08 |
$82,354,000 |
| 10787495 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2020-09-29 |
$182,772,000 |
| 10640544 |
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2020-05-05 |
$74,079,000 |
| 10428134 |
Immunoglobulins and uses thereof |
Mark J. Macielag, Rui Zhang, Martin A. Case, Shamina M. Rangwala, James N. Leonard +9 more |
2019-10-01 |
$150,887,000 |
| 9193736 |
PDE 10a inhibitors for the treatment of type II diabetes |
Mark R. Player, Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson +4 more |
2015-11-24 |
$122,826,000 |
| 8796256 |
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators |
Gilles Bignan, Wing S. Cheung, Micheal Gaul, Hui Huang, Xun Li +5 more |
2014-08-05 |
$40,134,000 |
| 8344009 |
Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulators |
Michael Gaul, Alexander Kim, Lily Lee Searle, Dionisois Rentzeperis, Guozhang Xu +1 more |
2013-01-01 |
|
| 7846953 |
Substituted phenoxy thiazolidinediones as estrogen related receptor-α modulators |
Michael Gaul, Alexander Kim, Lily Lee Searle, Dionisois Rentzeperis, Guozhang Xu +1 more |
2010-12-07 |
$49,695,000 |
| 7790724 |
c-fms kinase inhibitors |
Mark R. Player, Nand Baindur, Benjamin Brandt, Naresh Chadha, Davoud Asgari +1 more |
2010-09-07 |
$62,281,000 |
| 7608622 |
Imidazo[4,5-b]pyrazinone inhibitors of protein kinases |
Jian Liu, Mark R. Player, Huaping Hu |
2009-10-27 |
$135,214,000 |
| 7429603 |
C-fms kinase inhibitors |
Mark R. Player, Nand Baindur, Benjamin Brandt, Naresh Chadha, Davoud Asgari +1 more |
2008-09-30 |
|
| 7427683 |
c-fms kinase inhibitors |
Mark R. Player, Nand Baindur, Benjamin Brandt, Naresh Chadha, Davoud Asgari +1 more |
2008-09-23 |
|
| 7326788 |
Quinolinone derivatives as inhibitors of c-fms kinase |
Mark Wall, Mark R. Player, Sanath K. Meegalla, Jian Liu, Carl R. Illig +3 more |
2008-02-05 |
$235,792,000 |
| 7247438 |
Methods of identifying agents which enhance caspase activity |
Ellis L. Reinherz, Linda Clayton, Timothy D. Ocain |
2007-07-24 |
$32,547,000 |
| 6365625 |
Compound for inhibiting HIV infectivity |
Shyam K. Singh, Peter V. Pallai, Edith A. Neidhardt, Gerard Palace, Kevin J. Willis +3 more |
2002-04-02 |
|
